White Paper

Pharmaceutical Industry Transparency Resourcing: Time to consider outsourcing?

Pharmaceutical Industry Transparency Resourcing: Time to consider outsourcing?

Pages 9 Pages

This white paper examines whether life sciences companies should outsource transparency reporting. It highlights how the Sunshine Act and similar regulations demand routine yet resource-heavy compliance, while internal expertise is shrinking due to labor market pressures. Challenges include administrative burden, data remediation, and risk from reliance on few specialists. Outsourcing can reduce risk, free resources for strategic work, and provide scalable expertise and technology. IQVIA’s end-to-end model offers reporting, analytics, compliance monitoring, and flexible staffing to simplify operations and improve efficiency.

Join for free to read